A MOUSE MODEL REVEALS VULNERABILITY OF IDH1-MUTATED GLIOMA TO FERROPTOSIS

被引：0
|
作者：
Mela, Angeliki [1 ]
Dovas, Athanassios [1 ]
Mahajan, Aayushi [1 ]
Humala, Nelson [1 ]
Trang Nguyen [1 ]
Kanangat, Smriti [1 ]
Upadhyayula, Pavan [1 ]
Sprinzen, Lisa [2 ]
Argenziano, Michael [1 ]
Huang, Dennis [3 ]
Guo, Jia [4 ]
Casaccia, Patrizia [3 ]
Siegelin, Markus [1 ]
Stockwell, Brent [4 ]
Bruce, Jeffrey [1 ]
Canoll, Peter [5 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Univ Calif San Francisco, San Francisco, CA USA
[3] CUNY, ASRC, New York, NY USA
[4] Columbia Univ, New York, NY USA
[5] Columbia Univ, Irving Med Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-20
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CHARACTERISTICS OF THE TUMOR MICROENVIRONMENT IN IDH1-MUTATED CHOLANGIOCARCINOMA PATIENTS FROM CLARIDHY TRIAL
    Saatcioglu, H. Duygu
    Valle, Juan
    Macarulla, Teresa
    Javle, Milind
    Oh, Do-Youn
    Goyal, Lipika
    Conway, Jake
    Iyer, Janani
    Najdawi, Fedaa
    Shah, Chintan
    Gliser, Camelia
    Pandya, Susan
    Daigle, Scott
    Abou-Alfa, Ghassan
    Kelley, Robin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A576 - A577
  • [32] STAT5 Signaling Promotes Resistance to Ivosidenib in IDH1-Mutated AML
    Liu, Alex
    Cathelin, Severine
    Chan, Steven M.
    BLOOD, 2021, 138
  • [33] Profiling the metabolic effects of AGI-5198 treatment on IDH1-mutated gliomas
    Rodado, Victor Ruiz
    Lita, Adrian
    Dowdy, Tyrone
    Gilbert, Mark R.
    Larion, Mioara
    CANCER RESEARCH, 2017, 77
  • [34] Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation
    Azar, S.
    Leventoux, N.
    Ripoll, C.
    Rigau, V.
    Goze, C.
    Lorcy, F.
    Bauchet, L.
    Duffau, H.
    Guichet, P. O.
    Rothhut, B.
    Hugnot, J. P.
    GLIA, 2018, 66 (02) : 239 - 255
  • [35] Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours
    Molenaar, Remco J.
    Coelen, Robert J. S.
    Khurshed, Mohammed
    Roos, Eva
    Caan, Matthan W. A.
    van Linde, Myra E.
    Kouwenhoven, Mathilde
    Bramer, Jos A. M.
    Bovee, Judith V. M. G.
    Mathot, Ron A.
    Klumpen, Heinz-Josef
    van Laarhoven, Hanneke W. M.
    van Noorden, Cornelis J. F.
    Vandertop, W. Peter
    Gelderblom, Hans
    van Gulik, Thomas M.
    Wilmink, Johanna W.
    BMJ OPEN, 2017, 7 (06):
  • [36] The mRNA-binding protein HuR, regulates mutant and wild type IDH1 expression in IDH1-mutated cancer
    Zarei, Mahsa
    Lal, Shruti
    Mambelli-Lisboa, Nicole C.
    Cheung, Edwin
    Chand, Saswati N.
    Yeo, Charles J.
    Brody, Jonathan R.
    Winter, Jordan M.
    CANCER RESEARCH, 2016, 76
  • [37] Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
    van Noorden, Cornelis J. F.
    Hira, Vashendriya V. V.
    van Dijck, Amber J.
    Novak, Metka
    Breznik, Barbara
    Molenaar, Remco J.
    CELLS, 2021, 10 (03) : 1 - 16
  • [38] Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL
    Karpel-Massler, Georg
    Ishida, Chiaki Tsuge
    Bianchetti, Elena
    Zhang, Yiru
    Shu, Chang
    Tsujiuchi, Takashi
    Banu, Matei A.
    Garcia, Franklin
    Roth, Kevin A.
    Bruce, Jeffrey N.
    Canoll, Peter
    Siegelin, Markus D.
    NATURE COMMUNICATIONS, 2017, 8
  • [39] Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
    Jin, Genglin
    Reitman, Zachary J.
    Duncan, Christopher G.
    Spasojevic, Ivan
    Gooden, David M.
    Rasheed, B. Ahmed
    Yang, Rui
    Lopez, Giselle Y.
    He, Yiping
    McLendon, Roger E.
    Bigner, Darell D.
    Yan, Hai
    CANCER RESEARCH, 2013, 73 (02) : 496 - 501
  • [40] Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
    Rimini, Margherita
    Loi, Eleonora
    Fabregat-Franco, Carles
    Burgio, Valentina
    Lonardi, Sara
    Niger, Monica
    Scartozzi, Mario
    Raposelli, Ilario G.
    Aprile, Giuseppe
    Ratti, Francesca
    Pedica, Federica
    Verdaguer, Helena
    Rizzato, Mario
    Nichetti, Federico
    Lai, Eleonora
    Cappetta, Alessandro
    Macarulla, Teresa
    Fassan, Matteo
    De Braud, Filippo
    Pretta, Andrea
    Simionato, Francesca
    De Cobelli, Francesco
    Aldrighetti, Luca
    Fornaro, Lorenzo
    Cascinu, Stefano
    Patrizia, Zavattari
    Casadei-Gardini, Andrea
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 299 - 310
12345